Oral Presentation Asia Pacific Stroke Conference 2024

Impact of Post-Stroke Aphasia on Prognosis after Stroke (107168)

Tomotaka TT Tanaka 1 , Satoshi SS Saito 1 , Sonu BS Bhaskar 1 , Soichiro AS Abe 1 , Hiroyuki IH Ishiyama 1 , Kazuki FK Fukuma 1 , Eriko YE Yamaguchi 1 , Shinsaku NS Nakazawa 1 , Miho YM Yamauchi 1 , Yuriko NY Nakaoku 1 , Soshiro OS Ogata 1 , Kunihiro NK Nishimura 1 , Chiaki YC Yokota 1 , Masatoshi KM Koga 1 , Kazunori TK Toyoda 1 , Masafumi IM Ihara 1
  1. National Cerebral and Cardiovascular Center, Suita, OSAKA, Japan

Background and Aims:

Post-stroke aphasia (PSA) poses a significant challenge as only a limited number of studies have investigated its impact on stroke prognosis, including functional morbidity and mortality.

Methods:

This single-center retrospective study involved ischemic stroke cases admitted within 7 days of onset between January 2011 and December 2023 from NCVC stroke registry. PSA was defined based on the language sub-score of the NIHSS at discharge. The effect of aphasia at discharge on modified Rankin Scale (mRS) deterioration at 3 months and 1 year and mortality was assessed by multivariable analysis, adjusting for age, sex, mRS at discharge, comorbidities, transfer to rehabilitation, and antithrombotic drugs use.

Results

A total of 6,271 cases (mean age:74.3 ±12.3 years, female:38.1%) included cardioembolic (27.6%), atherothrombotic (16.7%), lacunar (17.2%), and other strokes (38.5%). Follow-up rates were 100% at 3 months and 77.5% at 1 year. At discharge, median mRS was 2 (IQR 1-4), with aphasia in 17.7%. Worsening of mRS was observed in 21.7% at 3 months and 23.8% at 1 year. Multivariable analyses revealed significant associations between PSA and poor prognosis at 3 months (OR 2.24, 95% CI 1.89-2.66) and 1 year (OR 1.70, 95% CI 1.40-2.06). Mortality was also significant at 3 months (OR 2.85, 95% CI 2.05-3.97) and 1 year (OR 2.36, 95% CI 1.84-3.02).

Conclusions

PSA independently predicted poor functional morbidity and mortality at 3 months and 1 year. The presence of PSA should be recognized as an independent predictor of poor prognosis in stroke.